Search Results
Viewing: 801-810 of 3139 | All
Article
Rajappa Lab
Under the direction of Prajwal Rajappa, MD, MS, the Rajappa Laboratory at the Steve and Cindy Rasmussen Institute for Genomic Medicine focuses on precision medicine and immunotherapy for patients diagnosed with central nervous system (CNS) tumors.
Article
Saad Lab
Under the direction of Nizar Saad, MSc, PhD, the Saad Lab conducts cutting-edge research to understand the causes of genetic disorders, including neuromuscular diseases, and develops innovative techniques to diagnose, treat and cure these conditions.
News
Nationwide Foundation Pediatric Innovation Fund Accelerating Lifesaving Progress at Newly-Formed Institute For Genomic Medicine at Nationwide Childrens Hospital
The Nationwide Foundation today announced a new $10 million gift for the Nationwide Foundation Pediatric Innovation Fund at Nationwide Children’s Hospital to help accelerate the most promising research and clinical discoveries at Nationwide Children’s.
News
St. Baldrick's Foundation Funds $8.9 Million in Grants to Support the Most Promising Childhood Cancer Research
No hospital has a monopoly on good ideas. This is why the St. Baldrick's Foundation funds the most promising research — no matter where it takes place – from your backyard institution to other cutting edge research facilities treating childhood cancers around the globe. Since 2005, this philosophy has translated to more than 1,674 grants in 31 countries, totaling more than $322 million. Thanks to the tremendous efforts of volunteers, donors, partners and advocates across the country this past year, St. Baldrick's is proud to announce $8.9 million has been awarded in new grants.
Article
Exceptional Responders
The National Cancer Institute (NCI) has embarked on the Exceptional Responders (ER) Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
News
Researchers at Nationwide Childrens Hospital Receive New Grant to Study How Pediatric Brain Tumor, Ependymoma, Develops
Armed with new grant support, investigators at Nationwide Children’s Hospital plan to examine how a common gene of the nervous system leads to the development of a devastating brain tumor, ependymoma. Robert A.
News
Cystic Fibrosis Research and Development Program Awarded $2 Million Grant From Cystic Fibrosis Foundation
A team of researchers at Nationwide Children's Hospital and The Ohio State University (OSU) College of Medicine recently was awarded a $2 million grant over four years to continue development of the Cure CF Columbus Research and Development Program (C3 RDP).
Blog
Down Syndrome Life Expectancy Is Higher, But Not For Everyone
Over 6,000 babies are born with Down syndrome in the United States each year. As recently as 1983, a person with Down syndrome lived to be only 25 years old on average. Today, the average life expectancy of a person with Down syndrome is nearly 60 years and continuing to climb.
Article
DISCOVERYx 2016
DISCOVERYx 2016 is a TEDx-inspired event that showcased ten presenters sharing their "story behind discovery” here at Nationwide Children’s. Last year's event was held on June 15, 2016.
News
Nationwide Childrens Hospital Researchers Receive NIH Grant for the Move Toward Clinical Trials Targeting the Lysosomal Storage Disease MPSIIIB
Investigators at Nationwide Children’s have received a grant from the National Institutes of Health (NIH) to help move a therapy for MPS IIIB that has been shown effective in mice toward clinical trials in humans.